speb/financial-data huggingface dataset:
Stock screener scorecard for 3372.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3027424512 (Mid Cap ($2B-$10B))
P/E ratio: 0.1515619601902788
Debt to equity: 0.5249
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3407.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2484481294336 (Mega Cap (>= $200B))
P/E ratio: 0.08068966402299735
Debt to equity: 0.4669
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3441.T (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 11325864960 (Large Cap ($10B-$200B))
P/E ratio: 0.02775719594373069
Debt to equity: 0.5702
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3649.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 20576901120 (Large Cap ($10B-$200B))
P/E ratio: 0.10189188589428254
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 3834.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 16479394816 (Large Cap ($10B-$200B))
P/E ratio: 0.08149381513585258
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4592.T (quarterly, report date 2026-04-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 74685562880 (Large Cap ($10B-$200B))
Debt to equity: 0.0931
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 556A.T (quarterly, report date 2026-04-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5399554560 (Mid Cap ($2B-$10B))
P/E ratio: 0.10798599887031632
Debt to equity: 0.04318475394046323
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 556A.T (annual, report date 2026-04-30)
Altman Z-score: 9.220500963835107 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 28.7789805084551%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 32.89643887110253%
Free cash flow margin: 10.774641118945343%
Revenue growth: 37.60025538583076%
Rule of 40 score: 48.3748965047761
Market cap: 5399554560 (Mid Cap ($2B-$10B))
P/E ratio: 0.10798599887031632
Debt to equity: 0.04318475394046323
Free cash flow (dilution adjusted): 3023467.349232114
Operating income: 3750074.915719815
Net income: 3096572.605818454
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 6060.HK (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.4837992403104465%
Capitalized R&D asset: 0
Free cash flow margin: 7.160142691405204%
Revenue growth: 8.103653283347304%
Rule of 40 score: 15.263795974752508
Market cap: 17926410240 (Large Cap ($10B-$200B))
P/E ratio: 2.550065060776286
Debt to equity: 0.33590000000000003
Free cash flow (dilution adjusted): 355673142.85714287
Net income: 157372142.85714287
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6060.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 17926410240 (Large Cap ($10B-$200B))
P/E ratio: 2.550065060776286
Debt to equity: 0.33590000000000003
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6198.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1819701248 (Small Cap ($300M-$2B))
Debt to equity: 0.3181
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6485.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 31432640512 (Large Cap ($10B-$200B))
P/E ratio: 0.07435068154536573
Debt to equity: 0.0002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6630.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 40330526720 (Large Cap ($10B-$200B))
Debt to equity: 0.0040999999999999995
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7129.T (annual, report date 2026-03-31)
Altman Z-score: 2.181664599529356 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.113031387461598%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.523062382566044%
Free cash flow margin: 2.0674522305885916%
Revenue growth: -2.3670521111044796%
Rule of 40 score: -0.29959988051588793
Market cap: 3242121216 (Mid Cap ($2B-$10B))
P/E ratio: 0.09934303465601388
Debt to equity: 1.4963
Free cash flow (dilution adjusted): 3214314.314314314
Operating income: 5157038.288288288
Net income: 1256575.3253253254
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 7129.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3242121216 (Mid Cap ($2B-$10B))
P/E ratio: 0.09934303465601388
Debt to equity: 1.4963
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7821.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 122902364160 (Large Cap ($10B-$200B))
P/E ratio: 0.0852046583953983
Debt to equity: 0.042
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8036.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 49325088 (Nano Cap (< $50M))
Debt to equity: 0.0347
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 8036.HK (annual, report date 2025-12-31)
Altman Z-score: 4.97486018670703 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.2879162545334655%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.757273196763641%
Free cash flow margin: -7.178217821782179%
Revenue growth: -13.438869982551587%
Rule of 40 score: -20.617087804333767
Market cap: 49325088 (Nano Cap (< $50M))
Debt to equity: 0.0347
Free cash flow (dilution adjusted): -249742.93059125965
Operating income: -728534.7043701799
Net income: -478920.3084832905
Long score: 4 | Short score: 12
Recommendation: Short
Stock screener scorecard for 8148.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 760529664 (Small Cap ($300M-$2B))
P/E ratio: 17.095115681233935
Debt to equity: 0.1027
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 8481.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 127628544 (Micro Cap ($50M-$300M))
P/E ratio: 0.2693108091565675
Debt to equity: 1.6735
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8481.HK (annual, report date 2025-12-31)
Altman Z-score: 1.2849330792462998 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -64.54907939988608%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.395049314514852%
Free cash flow margin: -39.54477785213816%
Revenue growth: 4.3012062564046865%
Rule of 40 score: -35.24357159573347
Market cap: 127628544 (Micro Cap ($50M-$300M))
P/E ratio: 0.2693108091565675
Debt to equity: 1.6735
Free cash flow (dilution adjusted): -33089714.285714287
Operating income: 13372285.714285715
Net income: 10835428.57142857
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 8931.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15669253120 (Large Cap ($10B-$200B))
P/E ratio: 0.03365152992523542
Debt to equity: 2.0444999999999998
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 9363.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2478275328 (Mid Cap ($2B-$10B))
P/E ratio: 0.04516039448638376
Debt to equity: 1.0885
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9363.T (annual, report date 2026-03-31)
Altman Z-score: 3.0803046798587044 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.906823162144033%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.125864519496207%
Free cash flow margin: 5.52106373589631%
Revenue growth: -0.5729834452775375%
Rule of 40 score: 4.948080290618773
Market cap: 2478275328 (Mid Cap ($2B-$10B))
P/E ratio: 0.04516039448638376
Debt to equity: 1.0885
Free cash flow (dilution adjusted): 3181825.5755755757
Operating income: 2173060.5605605603
Net income: 2093950.2002002
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for AA2.AX (annual, report date 2025-12-31)
Altman Z-score: 45.60459636822762 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -27.311380295413777%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.716237323184547%
Rule of 40 score: 0
Market cap: 83415216 (Micro Cap ($50M-$300M))
Debt to equity: 0.0139
Free cash flow (dilution adjusted): -5856756.756756756
Operating income: -4125675.6756756757
Net income: -16702702.702702703
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for AA2.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 83415216 (Micro Cap ($50M-$300M))
Debt to equity: 0.0139
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AGL.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5597257216 (Mid Cap ($2B-$10B))
Debt to equity: 0.9473999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AGL.AX (annual, report date 2025-06-30)
Altman Z-score: 1.0517524021399811 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -28.131279303415944%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.2515832393510888%
Free cash flow margin: -2.0520231213872835%
Revenue growth: 3.403653795003738%
Rule of 40 score: 1.3516306736164547
Market cap: 5597257216 (Mid Cap ($2B-$10B))
Debt to equity: 0.9473999999999999
Free cash flow (dilution adjusted): -185620915.03267974
Operating income: 18954248.366013072
Net income: -64052287.58169935
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for AKO.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 18261176 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AKO.AX (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.545811668217162%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -12.832497609921113%
Rule of 40 score: 0
Market cap: 18261176 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -2208768.4563758387
Operating income: -1338663.7583892618
Net income: -1335148.9932885906
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for ALLPL.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1358342 (Nano Cap (< $50M))
Debt to equity: -0.8824230426780905
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ALLPL.PA (annual, report date 2025-12-31)
Altman Z-score: -0.1570957968332949 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -16.499583301729423%
Revenue growth: -27.183885375023486%
Rule of 40 score: -43.68346867675291
Market cap: 1358342 (Nano Cap (< $50M))
Debt to equity: -0.8824230426780905
Free cash flow (dilution adjusted): -1640438.8470588236
Operating income: -1836929.411764706
Net income: -2397230.588235294
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ALPAS.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 19114008 (Nano Cap (< $50M))
P/E ratio: 8.10246679316888
Debt to equity: 0.16469999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ALPAS.PA (annual, report date 2025-12-31)
Altman Z-score: 3.372297195088679 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.756160213110077%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.180563343829531%
Free cash flow margin: 11.242495605161034%
Revenue growth: 7.310312609491179%
Rule of 40 score: 18.552808214652213
Market cap: 19114008 (Nano Cap (< $50M))
P/E ratio: 8.10246679316888
Debt to equity: 0.16469999999999999
Free cash flow (dilution adjusted): 7975294.117647059
Operating income: 4462352.94117647
Net income: 3077647.0588235296
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for ANGS.L (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15422894 (Nano Cap (< $50M))
Debt to equity: 0.46659999999999996
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ARC.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5582829 (Nano Cap (< $50M))
Debt to equity: 0.4175
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ARCC (quarterly, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.6541059367223605%
Capitalized R&D asset: 0
Free cash flow margin: 121.8543046357616%
Revenue growth: -56.104651162790695%
Rule of 40 score: 65.74965347297089
Market cap: 13484469248 (Large Cap ($10B-$200B))
P/E ratio: 10.648484848484848
Debt to equity: 1.1291
Free cash flow (dilution adjusted): 184000000
Net income: 92000000
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for AREN (quarterly, report date 2026-03-31)
Altman Z-score: -4.04884822894635 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.32772040275112657%
Free cash flow margin: 4.057630108791532%
Revenue growth: -27.743351864310757%
Rule of 40 score: -23.685721755519225
Market cap: 39034288 (Nano Cap (< $50M))
P/E ratio: 4.717391304347826
Debt to equity: -13.477961989486454
Free cash flow (dilution adjusted): 828000
Operating income: -304000
Net income: -2658000
Long score: 3 | Short score: 12
Recommendation: Short
Stock screener scorecard for ATXG (annual, report date 2026-03-31)
Altman Z-score: 2.048718261834517 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -25.72151068648192%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.835458186393474%
Free cash flow margin: -15.908934772842409%
Revenue growth: 34.976228309149704%
Rule of 40 score: 19.067293536307297
Market cap: 3816309 (Nano Cap (< $50M))
Debt to equity: 0.0809
Free cash flow (dilution adjusted): -123661.07091172214
Operating income: -221150.36179450073
Net income: -646767.7279305354
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for ATXG (quarterly, report date 2026-03-31)
Altman Z-score: 2.057597413301846 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.5670273917146773%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.499810881617773%
Free cash flow margin: 16.269465570527966%
Revenue growth: 185.3088824605097%
Rule of 40 score: 201.57834803103765
Market cap: 3816309 (Nano Cap (< $50M))
P/E ratio: 44.1580151906833
Debt to equity: 0.0809
Free cash flow (dilution adjusted): 64708.53835021707
Operating income: -94737.04775687409
Net income: 32175.397973950796
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for BLDP (quarterly, report date 2026-03-31)
Altman Z-score: 4.918417209845211 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.9027476825730878%
Capitalized R&D asset: 14817773.250013128
ROCI (R&D adjusted): -2.2838714852040787%
Rosenberg metric: -0.2632798862391162
Free cash flow margin: -49.97168014005457%
Revenue growth: -43.0954243680387%
Rule of 40 score: -93.06710450809328
Market cap: 874279936 (Small Cap ($300M-$2B))
Debt to equity: 0.0362
Free cash flow (dilution adjusted): -6982014.388489209
Operating income: -9401438.848920863
Net income: -8195683.453237411
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for BTU.V (quarterly, report date 2026-01-31)
Altman Z-score: 52.74079963712956 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.5698814458517512%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.66058325022035%
Rule of 40 score: 0
Market cap: 7982371 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -84409.62962962962
Operating income: -91228.88888888888
Net income: -86245.92592592593
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CAR.L (quarterly, report date 2025-09-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 23273884 (Nano Cap (< $50M))
P/E ratio: 0.19932432432432431
Debt to equity: -3.398207696362681
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CBSM.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 135025344 (Micro Cap ($50M-$300M))
Debt to equity: 0.8249266721161704
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CEC.V (quarterly, report date 2026-03-31)
Altman Z-score: 1.7336135564929451 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.60734463276836%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.887869520897045%
Rule of 40 score: 0
Market cap: 34966112 (Nano Cap (< $50M))
Debt to equity: 0.0171
Free cash flow (dilution adjusted): -443165.46762589936
Operating income: -488489.20863309357
Net income: -484892.0863309353
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CHS.V (quarterly, report date 2026-03-31)
Altman Z-score: -17.37232917809394 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 691621.12
Rosenberg metric: 0.866840647550095
Free cash flow margin: -133.8246795457777%
Revenue growth: 29.56576286502634%
Rule of 40 score: -104.25891668075137
Market cap: 11226654 (Nano Cap (< $50M))
Debt to equity: -0.6373550255146812
Free cash flow (dilution adjusted): -1581069
Operating income: -529775
Net income: -494588
Long score: 1 | Short score: 11
Recommendation: Short
Stock screener scorecard for COBH.BR (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 137250000 (Micro Cap ($50M-$300M))
Debt to equity: 0.2773406896551724
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for COBH.BR (annual, report date 2025-12-31)
Altman Z-score: 2.0109160076349277 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.4316963173168908%
Revenue growth: 9.940937196972563%
Rule of 40 score: 9.940937196972563
Market cap: 137250000 (Micro Cap ($50M-$300M))
Debt to equity: 0.2773406896551724
Operating income: -631764.705882353
Net income: -13417647.05882353
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for CP8.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 46618388 (Nano Cap (< $50M))
Debt to equity: -0.0032
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CP8.AX (annual, report date 2025-12-31)
Altman Z-score: 38.59046506700962 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -29.843265629664195%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.803581666158252%
Free cash flow margin: -44.32725010459049%
Revenue growth: -0.05783681666870061%
Rule of 40 score: -44.38508692125919
Market cap: 46618388 (Nano Cap (< $50M))
Debt to equity: -0.0032
Free cash flow (dilution adjusted): -686214.0939597315
Operating income: -1089679.8657718122
Net income: -1483318.1208053692
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for DEME.BR (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4248379904 (Mid Cap ($2B-$10B))
P/E ratio: 13.247913026596779
Debt to equity: 0.5105
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DFP (annual, report date 2025-11-30)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.225214997295057%
Capitalized R&D asset: 0
Free cash flow margin: 74.42051363106643%
Revenue growth: -52.115510788298614%
Rule of 40 score: 22.305002842767813
Market cap: 423291008 (Small Cap ($300M-$2B))
P/E ratio: 10.861702127659576
Debt to equity: 0.5901252906260266
Free cash flow (dilution adjusted): 29625455
Net income: 38510922
Long score: 3 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for DFP (quarterly, report date 2025-11-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 423291008 (Small Cap ($300M-$2B))
P/E ratio: 10.861702127659576
Debt to equity: 0.5901252906260266
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DSGN (quarterly, report date 2026-03-31)
Altman Z-score: 34.5704947705071 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.015904317279206%
Capitalized R&D asset: 28188120
ROCI (R&D adjusted): -7.832068347093054%
Rule of 40 score: 0
Market cap: 735743168 (Small Cap ($300M-$2B))
Debt to equity: 0.0125
Free cash flow (dilution adjusted): -20355000
Operating income: -19706000
Net income: -17636000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for HROW (quarterly, report date 2026-03-31)
Altman Z-score: 1.9014876913392513 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 14846000
ROCI (R&D adjusted): -6.754726150556446%
Rosenberg metric: -3.7173931587477607
Free cash flow margin: -70.2033798610954%
Revenue growth: -50.384995285772014%
Rule of 40 score: -120.5883751468674
Market cap: 1433227904 (Small Cap ($300M-$2B))
Debt to equity: 10.6052
Free cash flow (dilution adjusted): -31032000
Operating income: -22080000
Net income: -27602000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for HT8.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8224380 (Nano Cap (< $50M))
Debt to equity: 2.0781
Long score: 0 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for IDEX.V (quarterly, report date 2026-04-30)
Altman Z-score: 14.249049504040402 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -64.08954384873795%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -56.43571280779484%
Rule of 40 score: 0
Market cap: 25973856 (Nano Cap (< $50M))
Debt to equity: 0.042800000000000005
Free cash flow (dilution adjusted): -922516.7883211679
Operating income: -1136817.518248175
Net income: -1150076.6423357662
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for IMC.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 12268227 (Nano Cap (< $50M))
Debt to equity: 0.015600000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IMDA.PA (annual, report date 2025-12-31)
Altman Z-score: 0.6328335788840912 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.459642172122127%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.6115882648875752%
Free cash flow margin: 78.67041632842398%
Revenue growth: 30.83348644243591%
Rule of 40 score: 109.5039027708599
Market cap: 361034240 (Small Cap ($300M-$2B))
P/E ratio: 14.508830827616407
Debt to equity: 0.5273
Free cash flow (dilution adjusted): 31923529.411764707
Operating income: 37498823.52941176
Net income: 33262352.94117647
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for IMDA.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 361034240 (Small Cap ($300M-$2B))
P/E ratio: 14.508830827616407
Debt to equity: 0.5273
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for INFOBEAN.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 7.232395151666375%
Rule of 40 score: 7.232395151666375
Market cap: 15254629376 (Large Cap ($10B-$200B))
P/E ratio: 0.19006205016520536
Debt to equity: 0.0355
Operating income: 2695432.007595738
Net income: 2280831.311319759
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ISC.TO (quarterly, report date 2026-03-31)
Altman Z-score: 2.3720355382963603 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.696687384557308%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.7987930372902636%
Free cash flow margin: 18.74807875875682%
Revenue growth: -7.021273091416965%
Rule of 40 score: 11.726805667339853
Market cap: 953163520 (Small Cap ($300M-$2B))
P/E ratio: 21.369746308216587
Debt to equity: 0.8133
Free cash flow (dilution adjusted): 8336690.647482015
Operating income: 11751798.56115108
Net income: 6591366.90647482
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for JXN (quarterly, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.422914911541702%
Capitalized R&D asset: 0
Free cash flow margin: 33.860433138535576%
Revenue growth: 51.35275754422477%
Rule of 40 score: 85.21319068276034
Market cap: 8318957568 (Mid Cap ($2B-$10B))
Debt to equity: 0.5126
Free cash flow (dilution adjusted): 985000000
Net income: -420000000
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for LBG.L (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 65860120 (Micro Cap ($50M-$300M))
P/E ratio: 0.24999999999999997
Debt to equity: 0.1729
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MMI (quarterly, report date 2026-03-31)
Altman Z-score: 4.844907460804491 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.6976951244693407%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.8719346049046321%
Free cash flow margin: -21.672391772177736%
Revenue growth: -29.71223611395778%
Rule of 40 score: -51.38462788613552
Market cap: 1149026432 (Small Cap ($300M-$2B))
Debt to equity: 0.1319
Free cash flow (dilution adjusted): -37161000
Operating income: -5776000
Net income: -3100000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for NSRX (annual, report date 2025-12-31)
Altman Z-score: 23.408042266505937 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -212.0664739884393%
Capitalized R&D asset: 816640.1154856542
ROCI (R&D adjusted): -67.59909963206195%
Rule of 40 score: 0
Market cap: 36537724 (Nano Cap (< $50M))
Debt to equity: 0.0426
Free cash flow (dilution adjusted): -1691509.433962264
Operating income: -1542138.3647798742
Net income: -1841509.433962264
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for NSRX (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 36537724 (Nano Cap (< $50M))
Debt to equity: 0.0426
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ODYS (quarterly, report date 2026-03-31)
Altman Z-score: 37.07078147279324 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -24.382176440013232%
Capitalized R&D asset: 1767623.8700759625
ROCI (R&D adjusted): -20.337474057240545%
Rosenberg metric: -0.046169161317415566
Free cash flow margin: -6275.609756097561%
Revenue growth: -81.20296415904961%
Rule of 40 score: -6356.812720256611
Market cap: 74659080 (Micro Cap ($50M-$300M))
Debt to equity: 0.0313
Free cash flow (dilution adjusted): -1628481.0126582277
Operating income: -1689240.5063291139
Net income: -1639556.9620253164
Long score: 4 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for OPTX (quarterly, report date 2026-03-31)
Altman Z-score: 12.20954010081026 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -7.484516513997824%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.3178352760042955%
Free cash flow margin: 1.5396954508621195%
Revenue growth: -13.216077027495887%
Rule of 40 score: -11.676381576633768
Market cap: 283973152 (Micro Cap ($50M-$300M))
Debt to equity: 1.2903
Free cash flow (dilution adjusted): 100286
Operating income: -776047
Net income: -897857
Long score: 4 | Short score: 11
Recommendation: Short
Stock screener scorecard for PII (quarterly, report date 2026-03-31)
Altman Z-score: 0.8221729472634383 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 183877000
ROCI (R&D adjusted): -0.5731975847519722%
Rosenberg metric: -0.4664778092540132
Free cash flow margin: -22.342798577199012%
Revenue growth: -13.694781206098133%
Rule of 40 score: -36.03757978329715
Market cap: 4154965760 (Mid Cap ($2B-$10B))
Debt to equity: 2.9208999999999996
Free cash flow (dilution adjusted): -370600000
Operating income: -7500000
Net income: -47200000
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for PRAX (quarterly, report date 2026-03-31)
Altman Z-score: 107.4988798479491 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.56642275921107%
Capitalized R&D asset: 151629030
ROCI (R&D adjusted): -6.508515767953087%
Rule of 40 score: 0
Market cap: 9068964864 (Mid Cap ($2B-$10B))
Debt to equity: 0.001
Free cash flow (dilution adjusted): -103326000
Operating income: -105860000
Net income: -92561000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for RAYMONDLSL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.0820110914517982 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.455479973369965%
Revenue growth: -8.583383808777956%
Rule of 40 score: -8.583383808777956
Market cap: 43544592384 (Large Cap ($10B-$200B))
P/E ratio: 1.0504815762763484
Debt to equity: 0.2268
Operating income: -5263883.001271726
Net income: -5517168.2916490035
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for RSMX.V (annual, report date 2025-12-31)
Altman Z-score: 10.189286204522025 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -34.427835305272815%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -20.490398507077305%
Rule of 40 score: 0
Market cap: 14492740 (Nano Cap (< $50M))
Debt to equity: 0.0033
Free cash flow (dilution adjusted): -2938321.8978102184
Operating income: -1731957.6642335765
Net income: -1886232.116788321
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for RSMX.V (quarterly, report date 2025-12-31)
Altman Z-score: 10.510696610698595 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -16.375612372052778%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.154862231940152%
Rule of 40 score: 0
Market cap: 14492740 (Nano Cap (< $50M))
Debt to equity: 0.0033
Free cash flow (dilution adjusted): -1346417.518248175
Operating income: -858343.0656934306
Net income: -891167.1532846715
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for SLQT (quarterly, report date 2026-03-31)
Altman Z-score: 0.4856139726591522 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.083833890710737%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.2556790895334404%
Free cash flow margin: 11.404325034286073%
Revenue growth: -19.767008873547294%
Rule of 40 score: -8.362683839261221
Market cap: 113744312 (Micro Cap ($50M-$300M))
P/E ratio: 1.2089260777592792
Debt to equity: 0.6102000000000001
Free cash flow (dilution adjusted): 49145000
Operating income: 35930000
Net income: 40197000
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for STO.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 25884749824 (Large Cap ($10B-$200B))
P/E ratio: 11.260253542132737
Debt to equity: 0.4813
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TOR.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 118736416 (Micro Cap ($50M-$300M))
Debt to equity: 0.005699999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TR8.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6391240 (Nano Cap (< $50M))
Debt to equity: 0.0001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TR8.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6391240 (Nano Cap (< $50M))
Debt to equity: 0.0001
Free cash flow (dilution adjusted): -61722.22222222222
Operating income: -134886.92810457517
Net income: -157472.54901960783
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for UPB (quarterly, report date 2026-03-31)
Altman Z-score: 13.929815047162162 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -13.336403559269067%
Capitalized R&D asset: 74359980
ROCI (R&D adjusted): -11.516896320755635%
Free cash flow margin: -5077.272727272727%
Revenue growth: 54.79041916167665%
Rule of 40 score: -5022.482308111051
Market cap: 348832128 (Small Cap ($300M-$2B))
Debt to equity: 0.0037
Free cash flow (dilution adjusted): -52499000
Operating income: -43615000
Net income: -40591000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for VBS.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 941950.9064900663
Rule of 40 score: 0
Market cap: 9253553 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for WCSB.V (quarterly, report date 2026-03-31)
Altman Z-score: -5.890800162798189 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.68773794625017%
Free cash flow margin: 7.195363118315943%
Revenue growth: -0.8541928215733766%
Rule of 40 score: 6.3411702967425665
Market cap: 5130621 (Nano Cap (< $50M))
P/E ratio: 5.755395683453237
Debt to equity: -0.05082435795049838
Free cash flow (dilution adjusted): 31830.215827338136
Operating income: -188100
Net income: -196134.53237410073
Long score: 3 | Short score: 8
Recommendation: Short
Stock screener scorecard for WRLD (quarterly, report date 2026-03-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.971774228177626%
Capitalized R&D asset: 0
Free cash flow margin: 54.00280346523406%
Revenue growth: 27.903012753337208%
Rule of 40 score: 81.90581621857126
Market cap: 949734912 (Small Cap ($300M-$2B))
P/E ratio: 17.007556675062972
Debt to equity: 1.7893999999999999
Free cash flow (dilution adjusted): 88733283
Net income: 36099484
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for WRLD (annual, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.927024191509004%
Capitalized R&D asset: 0
Free cash flow margin: 44.077553160803504%
Revenue growth: 2.735116054291844%
Rule of 40 score: 46.81266921509535
Market cap: 949734912 (Small Cap ($300M-$2B))
P/E ratio: 17.007556675062972
Debt to equity: 1.7893999999999999
Free cash flow (dilution adjusted): 236134045
Net income: 34586024
Long score: 3 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ZEO (quarterly, report date 2026-03-31)
Altman Z-score: -0.2353658107370878 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.727751981188629%
Free cash flow margin: -13.292070106630716%
Revenue growth: -28.990522065945655%
Rule of 40 score: -42.28259217257637
Market cap: 46580384 (Nano Cap (< $50M))
Debt to equity: 0.0276
Free cash flow (dilution adjusted): -1752552
Operating income: -4765124
Net income: -3512674
Long score: 2 | Short score: 13
Recommendation: Short
Stock screener scorecard for 0035.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2355461171.14 (Mid Cap ($2B-$10B))
Debt to equity: 1.8891302412936566
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3441.T (annual, report date 2025-07-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4254622691 (Mid Cap ($2B-$10B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4592.T (annual, report date 2026-01-31)
Altman Z-score: 43.18532157654731 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -28.505617967585334%
Capitalized R&D asset: 34118578.87605019
ROCI (R&D adjusted): -18.598061595368133%
Rule of 40 score: 0
Market cap: 144298443207 (Large Cap ($10B-$200B))
Debt to equity: 0.091049637598627
Free cash flow (dilution adjusted): -25243803.865238965
Operating income: -24776769.39148603
Net income: -25088874.37973361
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 6198.T (annual, report date 2025-09-30)
Altman Z-score: 5.049492684502789 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -20.866416159909285%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.40775271320811085%
Free cash flow margin: -2.3470962784838836%
Revenue growth: -14.115117688203064%
Rule of 40 score: -16.462213966686946
Market cap: 2457015960 (Mid Cap ($2B-$10B))
Debt to equity: 0.49889820216913205
Free cash flow (dilution adjusted): -2359084.791386272
Operating income: -61352.62449528937
Net income: -1010437.4158815612
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for 6630.T (annual, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 5776160.474124949
Rule of 40 score: 0
Market cap: 41792026050.30988 (Large Cap ($10B-$200B))
Debt to equity: 0.00483884195850078
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8931.T (annual, report date 2026-02-28)
Altman Z-score: 1.4101195226443246 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.095646075646828%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.152500454934049%
Free cash flow margin: -28.22212755902937%
Revenue growth: 1.0773304841615337%
Rule of 40 score: -27.14479707486784
Market cap: 19427682960 (Large Cap ($10B-$200B))
P/E ratio: 7.405295993687786
Debt to equity: 1.886574242278275
Free cash flow (dilution adjusted): -76312986.01308866
Operating income: 32005036.571281917
Net income: 16832317.46439112
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for ANGS.L (annual, report date 2025-09-30)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.773423147581136%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.135551862681167%
Free cash flow margin: 0.7995558023320377%
Revenue growth: -16.276587568212186%
Rule of 40 score: -15.477031765880149
Market cap: 0 (Nano Cap (< $50M))
P/E ratio: 0
Debt to equity: 0.461849357011635
Free cash flow (dilution adjusted): 194594.59459459456
Operating income: 2656756.756756757
Net income: 193243.24324324325
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for ARCC (annual, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.07249615868138%
Capitalized R&D asset: 0
Free cash flow margin: -114.01062416998673%
Revenue growth: -12.084063047285463%
Rule of 40 score: -126.0946872172722
Market cap: 13786038624 (Large Cap ($10B-$200B))
P/E ratio: 10.612808794457274
Debt to equity: 1.116845928202263
Free cash flow (dilution adjusted): -1717000000
Net income: 1299000000
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AREN (annual, report date 2025-12-31)
Altman Z-score: -0.8433513083607445 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -168.07625606353832%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 42.66841004184101%
Free cash flow margin: 21.635713649983682%
Revenue growth: 7.085388421612778%
Rule of 40 score: 28.72110207159646
Market cap: 190411160 (Micro Cap ($50M-$300M))
P/E ratio: 1.5250217046564898
Debt to equity: -20.735958549222797
Free cash flow (dilution adjusted): 29171000
Operating income: 40791000
Net income: 124858000
Long score: 8 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for BLDP (annual, report date 2025-12-31)
Altman Z-score: 3.1035443571490156 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -16.386967891168464%
Capitalized R&D asset: 111726554.92317902
ROCI (R&D adjusted): -13.532103250531028%
Rosenberg metric: 0.292962639731963
Free cash flow margin: -73.14783133742579%
Revenue growth: 48.745853068104125%
Rule of 40 score: -24.40197826932166
Market cap: 1049075659.3502002 (Small Cap ($300M-$2B))
Debt to equity: 0.03752987642601664
Free cash flow (dilution adjusted): -53056204.379562035
Operating income: -58229927.00729927
Net income: -66360583.941605836
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for BTU.V (annual, report date 2025-04-30)
Altman Z-score: 118.99098145559573 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -19.05074398233181%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.21043148286807%
Rule of 40 score: 0
Market cap: 7095440.5600000005 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -506668.8405797102
Operating income: -466722.46376811597
Net income: -947247.1014492754
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CAR.L (annual, report date 2025-03-31)
Altman Z-score: 1.043372250672681 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -19.175963111706086%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 20.553198433420366%
Free cash flow margin: 8.534140687515984%
Revenue growth: -6.259387470946813%
Rule of 40 score: 2.274753216569171
Market cap: 176206.06319999998 (Nano Cap (< $50M))
P/E ratio: 0.2020711733944954
Debt to equity: -2.5294763513513514
Free cash flow (dilution adjusted): 13435064.935064936
Operating income: 13085714.285714285
Net income: 1132467.5324675324
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CEC.V (annual, report date 2025-12-31)
Altman Z-score: -1.1366323674906487 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -59.34110906486597%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -39.491886139930834%
Rule of 40 score: 0
Market cap: 7895573.49 (Nano Cap (< $50M))
Debt to equity: 0.01635195639478295
Free cash flow (dilution adjusted): -2437226.2773722624
Operating income: -2167153.2846715325
Net income: -2167153.2846715325
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CHS.V (annual, report date 2025-12-31)
Altman Z-score: -45.94883377272777 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 1264549.2
Rosenberg metric: 0.7288060690874273
Free cash flow margin: -27.537753393115555%
Revenue growth: 9.324065539950048%
Rule of 40 score: -18.213687853165506
Market cap: 10015668.613138687 (Nano Cap (< $50M))
Debt to equity: -0.43037053698853545
Free cash flow (dilution adjusted): -1134727
Operating income: -1190095
Net income: -2144760
Long score: 1 | Short score: 11
Recommendation: Short